NASDAQ:DECK News 9 January 2026

Deckers stock jumps nearly 20% after Hoka-led outlook raise — what to watch before Monday’s open

Deckers shares surged 19.46% to $119.34 Friday after raising its fiscal 2026 outlook on stronger-than-expected Q3 results. Net sales rose 7.1% to $1.958 billion, with EPS at $3.33. The company cut its expected 2026 tariff impact to $25 million and plans over $1 billion in share buybacks. Analysts raised price targets, citing strong demand for UGG and HOKA.

31 January 2026

Earnings Reports·NASDAQ:DECK·Stock Market

Deckers Outdoor (DECK) stock price jumps as Hoka demand lifts outlook and tariff hit eases

Deckers Outdoor shares surged 16% to $115.54 after the company raised its full-year outlook and reported third-quarter sales up 7% to $1.96 billion, led by Hoka’s 18.5% revenue jump. The firm cut its estimated tariff impact for fiscal 2026 to $25 million from up to $75 million. Volume spiked to 5.7 million shares, nearly double the 50-day average.

30 January 2026

Earnings·NASDAQ:DECK·Stock Market

Deckers stock jumps 12% premarket after Hoka, UGG owner lifts outlook and buyback plan

Deckers shares surged 12.5% to $112.43 in premarket trading after the company raised its full-year sales and profit outlook. Fiscal Q3 net sales rose 7.1% to $1.96 billion, with Hoka revenue up 18.5%. Deckers expects fiscal-year share buybacks to exceed $1 billion. Gross margin slipped to 59.8% from 60.3% a year earlier.

30 January 2026

NASDAQ:DECK·Stock Market

Deckers Outdoor stock drops as Needham pulls DECK from Conviction List, putting Hoka growth back under a microscope

Deckers Outdoor shares dropped 4.2% to $102.85 Friday afternoon after Needham removed the company from its Conviction List, citing slower growth for UGG and Hoka brands and risks to margins. Needham kept its Buy rating and $115 price target. Deckers’ next earnings report is expected Jan. 29, with investor focus on promotions and margins.

9 January 2026

NASDAQ:DECK·Stock Market

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

7 February 2026

Novartis shares closed up 0.6% in Zurich at 119.96 francs Friday, with U.S. ADRs gaining 1.5%. The company broke ground on a new San Diego research center and reported a positive draft reimbursement recommendation for Kisqali in Canada. Investors are watching for the March 6 annual meeting and March 10 ex-dividend date tied to a proposed 3.70-franc payout.

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026

AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.

Wells Fargo stock jumps to $93.97 — here’s what could move WFC next week

7 February 2026

Wells Fargo shares rose 2.63% to $93.97 Friday as U.S. stocks rebounded. The stock traded ex-dividend for a $0.45 payout due March 1. Investors await delayed U.S. jobs and inflation data next week and a scheduled CFO appearance at a bank conference.

Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface

7 February 2026

Merck shares closed up 1.8% at $121.93 Friday after Health Canada approved its ENFLONSIA RSV antibody for infants. Guggenheim raised its price target to $140. Insider filings showed three executives sold shares this week. Merck’s stock ended just below its 52-week high, with about 13 million shares traded.

NASDAQ:DECK News 9 January 2026 - 31 January 2026

Deckers stock jumps nearly 20% after Hoka-led outlook raise — what to watch before Monday’s open

Deckers Outdoor (DECK) stock price jumps as Hoka demand lifts outlook and tariff hit eases

Deckers stock jumps 12% premarket after Hoka, UGG owner lifts outlook and buyback plan

Deckers Outdoor stock drops as Needham pulls DECK from Conviction List, putting Hoka growth back under a microscope

Stock Market Today

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

AstraZeneca stock price: What could move AZN next week as earnings loom

Wells Fargo stock jumps to $93.97 — here’s what could move WFC next week

Merck stock ends week near highs after Canada clears ENFLONSIA; insider sales surface